<DOC>
	<DOCNO>NCT02909803</DOCNO>
	<brief_summary>It know whether different lentil variety efficacy lower blood glucose . Similarly , carbohydrate component lentils responsible lower blood glucose know , bioavailability lentil metabolites polyphenol bioactive .</brief_summary>
	<brief_title>Measuring Glycemic Index Tracking Metabolites New Emerging Lentil Varieties</brief_title>
	<detailed_description>The overall aim work produce credible evidence substantiate food health claim post prandial blood glucose lower lentil . Although several study show lentil consumption result lower post prandial blood glucose , know whether different lentil variety efficacy . Similarly , carbohydrate component lentils responsible lower blood glucose know , bioavailability lentil metabolites polyphenol bioactive . The investigator hypothesize slowly digestible starch content lentil inversely related vivo glycemic response . The specific aim study : ( ) identify putative component ( ) lentil might account blood glucose lower effect , ( ii ) identify difference blood glucose reduction among lentil variety . These aim achieve three-step process . Firstly , vitro study pursue determine carbohydrate fraction 20 new emerge Canadian lentil variety . Secondly , result use choose 8 lentil variety different slowly digestible starch content human Glycemic Index study . Thirdly , identification lentil metabolites achieve collect extra capillary blood ( 200uL ) urine sample fast 120min measurement polyphenols metabolites use establish HPLC metabolomics technique .</detailed_description>
	<mesh_term>Hyperglycemia</mesh_term>
	<criteria>Male nonpregnant female , 1875 year age , inclusive Body mass index ( BMI ) &lt; 40 kg/mÂ² Willing maintain habitual diet , physical activity pattern , body weight throughout trial refrain smoking 12hr prior visit . Normal fast serum glucose ( &lt; 7.0mmol/L capillary correspond whole blood glucose &lt; 6.3mmol/L ) . Understanding study procedure willing provide inform consent participate study authorization release relevant protect health information study investigator . Failure meet one inclusion criterion Known history AIDS , hepatitis , diabetes heart condition Subjects use medication condition might , opinion Dr. Wolever , Medical Director GI Labs , either : 1 ) make participation dangerous subject others , 2 ) affect result . Major trauma surgical event within 3 month screen . Unwillingness inability comply experimental procedure follow GI Labs safety guideline . Known intolerance , sensitivity allergy ingredient study product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>glucose</keyword>
	<keyword>glycemic index</keyword>
	<keyword>lentil</keyword>
	<keyword>polyphenols</keyword>
	<keyword>metabolite</keyword>
	<keyword>bioavailability</keyword>
</DOC>